Literature DB >> 17826615

Infections in diabetes mellitus and hyperglycemia.

Smita Gupta1, Janak Koirala, Romesh Khardori, Nancy Khardori.   

Abstract

Infections in diabetes mellitus are relatively more common and serious. Diabetic patients run the risk of acute metabolic decompensation during infections, and conversely patients with metabolic decompensation are at higher risk of certain invasive infections. Tight glycemic control is of paramount importance during acute infected or high stress state. Infections in diabetic patients result in extended hospital stays and additional financial burden. Given the risks of not alleviating the metabolic dysregulation and the benefits of decent glycemic control, it is necessary that besides antimicrobial therapy, equal emphasis be placed on intensified glycemic control.

Entities:  

Mesh：

Year:  2007        PMID： 17826615     DOI： 10.1016/j.idc.2007.07.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  29 in total

1.  Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole.

Authors:  Marjolaine Morgand; Blandine Rammaert; Sylvain Poirée; Marie-Elisabeth Bougnoux; Hugo Tran; Romain Kania; Fabrice Chrétien; Gregory Jouvion; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 2.  [Peri-operative adjustment and treatment of diabetes mellitus].

Authors:  J F Zander; A Risse
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

3.  Missed opportunities for Hepatitis B vaccination among diabetic patients.

Authors:  Lale Ozisik; Mine Durusu Tanriover; Nursel Calik Basaran; S Gul Oz; Serhat Unal
Journal:  Hum Vaccin Immunother       Date:  2015-09-14       Impact factor: 3.452

Review 4.  Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.

Authors:  Perrine Parize; Marie-Olivia Chandesris; Fanny Lanternier; Sylvain Poirée; Jean-Paul Viard; Boris Bienvenu; Michaël Mimoun; Frédéric Méchai; Marie-France Mamzer; Philippe Herman; Marie-Elisabeth Bougnoux; Marc Lecuit; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

5.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

6.  Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.

Authors:  Ronghua Hu; Chang-Qing Xia; Edward Butfiloski; Michael Clare-Salzler
Journal:  Clin Immunol       Date:  2018-06-09       Impact factor: 3.969

7.  Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus.

Authors:  Anastasios Tentolouris; Anastasia Thanopoulou; Nikolaos Tentolouris; Ioanna Eleftheriadou; Christina Voulgari; Alexandros Andrianakos; Petros P Sfikakis
Journal:  Ann Transl Med       Date:  2018-10

8.  A case of successfully treated rhinocerebral mucormycosis: dental implications.

Authors:  Nikolaos Papadogeorgakis; Eleni Parara; Vassilios Petsinis; Christina Vourlakou
Journal:  Int J Dent       Date:  2011-02-15

9.  Feasibility of modified surviving sepsis campaign guidelines in a resource-restricted setting based on a cohort study of severe S. aureus sepsis [corrected].

Authors:  Weera Mahavanakul; Emma K Nickerson; Pramot Srisomang; Prapit Teparrukkul; Pichet Lorvinitnun; Mingkwan Wongyingsinn; Wirongrong Chierakul; Maliwan Hongsuwan; T Eoin West; Nicholas P Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  Risk factors of recurrence and life-threatening complications for patients hospitalized with chronic suppurative osteomyelitis of the jaw.

Authors:  Lin Chen; Tangxin Li; Wei Jing; Wei Tang; Weidong Tian; Cai Li; Lei Liu
Journal:  BMC Infect Dis       Date:  2013-07-11       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.